MAPT and Alzheimer disease: Fiandaca et al. found that the mean levels of total Tau, p-T181-tau, p-S396-tau, and Aβ1−42 in NDEVs isolated from plasma or serum of AD patients were significantly higher than that of healthy donors even 1 to 10 years before they were diagnosed with AD [181].